Merck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
1/7 11:30
Merck MRK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has given a positive opinion recommending the approval of its pulmonary arterial hypertension (PAH) drug Winrevair...